DLL3, Human (Rovalpituzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Search, find, compare suppliers for anti-DLL3, Human (Rovalpituzumab biosimilar) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | DLL3, Human (Rovalpituzumab biosimilar) |
| Clone | Rovalpituzumab |
| Host Species | Recombinant |
| Reactive Species | human |
| Isotype | IgG1 kappa |
| Format | purified |
| Size | 1mg, 5mg |
| Concentration | 1mg/ml |
| Applications | n/a |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Anti-Human DLL3 Recombinant Antibody. Rovalpituzumab tesirine (Rova-T) is an experimental antibody-drug conjugate targeting the protein DLL3 on tumor cells. It was originally developed by Stemcentrx and was purchased by AbbVie. It was tested for use in small-cell lung cancer, but development was terminated after unsuccessful phase III trial. |
| Immunogen | n/a |
| Other Names | Anti-DLL3 Recombinant Antibody, Research Grade Rovalpituzumab, Anti-Human DLL3 Recombinant Antibody, , Antibody Drug Analogues, Monoclonal Antibody, YR1386, Research Grade Biosimilars, Biosimilar Antibody |
| Gene, Accession # | CAS: 1613313-01-1 |
| Catalog # | YR1386 |
| Price | please inquire |
| Order / More Info | DLL3, Human (Rovalpituzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
| Product Specific References | n/a |
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806
info@kmdbioscience.com
Sales: sales@kmdbiosci.com
https://www.kmdbioscience.com
Profile of KMD BIOSCIENCE CO. LTD.
Return to Antibodies